Clinical trial
Urinary Sodium-Guided Optimization of Diuretic Therapy in Patients With Worsening Heart Failure: Rationale and Design of a Pragmatic Randomized Controlled Trial (SURE-HF Trial)
NCT07631780 is registered in ClinicalTrials.gov with Nurgul Ablakimova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary Sodium-Guided Optimization of Diuretic Therapy in Patients With Worsening Heart Failure: Rationale and Design of a Pragmatic Randomized Controlled Trial (SURE-HF Trial)
- Lead sponsor
- Nurgul Ablakimova
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2027
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congestion, heart failure, worsening heart failure